Current vaccines to influenza and other RNA viruses have been designed to generate neutralizing antibodies (Ab), but cannot protect against new strains that arise each year and evade Ab from previous seasons. CD4 memory cells, however, respond to elements of the virus that do not change, but current vaccines have not been designed to optimize CD4 memory and the memory cells do not persist as long as antibody. Thus our focus is to define the potential of CD4 memory to provide immunity and to learn which subsets are needed and how they act. Our studies have shown that CD4 memory cells elicit innate responses when challenged even without live pathogen or pathogen components and we suggest that they may therefore act to enhance immunity without the need for the stimulus provided by live virus. We have shown that they can protect against live virus by activating innate cell NK cells and B cells, and thus may be able to generate robust immunity to new viral pathogens and enhance long-term B cell memory. The mechanisms leading to NK induction are little known. With our collaborators in the program, we will analyze the mechanisms by which the various subsets of CD4 memory: 1) interact with innate NK cells;2) provide help for B cells in influenza and LCMV virus models and participate in heterosubtypic (response to different strain) and cross-reactive immunity and we will determine if memory cells can substitute for, or complement, the pathogen recognition pathways either induced by live virus or vaccine adjuvants in inducing NK cell activation. We will analyze the mechanisms involved in these CD4 helper activities. We will determine whether the memory cells have more potent activity because they are resistant to NK mediated killing and 3) we will examine these same CD4 memory responses in humans in collaboration with Project 4. We believe these studies will provide important insights into the potential of CD4 memory induction by vaccines that can provide superior immunity to respiratory pathogens while avoiding irnmunopathdiogy.

Public Health Relevance

Many viruses, such as influenza, mutate and undergo selection so they evade pre-existing Ab. Both infections and vaccines can induce CD4 memory T cells, which see mostly shared determinants and thus may provide immunity to new strains. Here we will determine how CD4 memory T cells can act to provide enhanced protection by helping NK cells and B cells and how they contribute to deleterious heterologous immunity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI109858-01
Application #
8665103
Study Section
Special Emphasis Panel (ZAI1-ZL-I (J1))
Project Start
Project End
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
1
Fiscal Year
2014
Total Cost
$477,699
Indirect Cost
$191,937
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Urban, Stina L; Berg, Leslie J; Welsh, Raymond M (2016) Type 1 interferon licenses naïve CD8 T cells to mediate anti-viral cytotoxicity. Virology 493:52-9
Bautista, Bianca L; Devarajan, Priyadharshini; McKinstry, K Kai et al. (2016) Short-Lived Antigen Recognition but Not Viral Infection at a Defined Checkpoint Programs Effector CD4 T Cells To Become Protective Memory. J Immunol 197:3936-3949
Stadinski, Brian D; Shekhar, Karthik; Gómez-Touriño, Iria et al. (2016) Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol 17:946-55
Zhou, Xin; Hopkins, Jacob W; Wang, Chongkai et al. (2016) IL-2 and IL-6 cooperate to enhance the generation of influenza-specific CD8 T cells responding to live influenza virus in aged mice and humans. Oncotarget 7:39171-39183
Stadinski, Brian D; Obst, Reinhard; Huseby, Eric S (2016) A ""hotspot"" for autoimmune T cells in type 1 diabetes. J Clin Invest 126:2040-2
Fonseca, Jairo Andres; Cabrera-Mora, Monica; Singh, Balwan et al. (2016) A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119. Sci Rep 6:34527
Che, Jenny W; Daniels, Keith A; Selin, Liisa K et al. (2016) Heterologous immunity and persistent murine cytomegalovirus infection. J Virol :
Strutt, Tara M; McKinstry, Karl Kai; Kuang, Yi et al. (2016) Direct IL-6 Signals Maximize Protective Secondary CD4 T Cell Responses against Influenza. J Immunol 197:3260-3270
Wyss, Lena; Stadinski, Brian D; King, Carolyn G et al. (2016) Affinity for self antigen selects Treg cells with distinct functional properties. Nat Immunol 17:1093-101
Devarajan, Priyadharshini; Bautista, Bianca; Vong, Allen M et al. (2016) New Insights into the Generation of CD4 Memory May Shape Future Vaccine Strategies for Influenza. Front Immunol 7:136

Showing the most recent 10 out of 29 publications